Celltrion Healthcare Co Ltd banner

Celltrion Healthcare Co Ltd
KOSDAQ:091990

Watchlist Manager
Celltrion Healthcare Co Ltd Logo
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Watchlist
Price: 75 900 KRW -5.6% Market Closed
Market Cap: ₩12.5T

Intrinsic Value

The intrinsic value for Celltrion Healthcare Co Ltd (091990) under the Base Case is 76 450.12 KRW. Compared with the current market price of 75 900 KRW, the stock appears Undervalued by 1% .

Intrinsic value calculated using DCF
₩76 450.12

Do our valuations actually work? See backtest results .

Intrinsic Value
76 450.12
Undervaluation 1%
Intrinsic Value
Price ₩75 900
Monitor Celltrion Healthcare Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ₩61 160.09
Get notified when the price drops into your buy zone
Intrinsic Value ₩76 450.12
Current Price ₩75 900
Margin of Safety 20% ₩61 160.09
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about Celltrion Healthcare Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Celltrion Healthcare Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Celltrion Healthcare Co Ltd.

Explain Valuation
Alternatives to Celltrion Healthcare Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Celltrion Healthcare Co Ltd stock?

The intrinsic value for Celltrion Healthcare Co Ltd (091990) under the Base Case is 76 450.12 KRW.

Is Celltrion Healthcare Co Ltd stock undervalued or overvalued?

Compared with the current market price of 75 900 KRW, the stock appears Undervalued by 1% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett